Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pieper

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
JAMA Cardiology|November 29, 2018
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation IIUtibe R Essien, DaJuanicia N Holmes, Larry R Jackson, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
American Heart Journal|August 13, 2011
Recalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian populationMark Y Chan, Bimal R Shah, Fei Gao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 11, 2019
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AFShinichi Goto, Shinya Goto, Karen S Pieper, et al.
JAMA Network Open|February 27, 2020
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial FibrillationKeith A A Fox, Priscilla Velentgas, A John Camm, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF RegistryFrank Cools, Dana Johnson, Alan J Camm, et al.
Blood Advances|February 19, 2021
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registryJean-Pierre Bassand, Saverio Virdone, Marc Badoz, et al.
JAMA Cardiology|May 9, 2019
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF RegistryRamon Corbalan, Jean-Pierre Bassand, Laura Illingworth, et al.
International Journal of Cardiology|February 21, 2012
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 yearsMark Y Chan, Jie-Lena Sun, L Kristin Newby, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillationKeith A A Fox, Saverio Virdone, Karen S Pieper, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
JAMA Cardiology|November 29, 2018
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation IIUtibe R Essien, DaJuanicia N Holmes, Larry R Jackson, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
American Heart Journal|August 13, 2011
Recalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian populationMark Y Chan, Bimal R Shah, Fei Gao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 11, 2019
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AFShinichi Goto, Shinya Goto, Karen S Pieper, et al.
JAMA Network Open|February 27, 2020
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial FibrillationKeith A A Fox, Priscilla Velentgas, A John Camm, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF RegistryFrank Cools, Dana Johnson, Alan J Camm, et al.
Blood Advances|February 19, 2021
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registryJean-Pierre Bassand, Saverio Virdone, Marc Badoz, et al.
JAMA Cardiology|May 9, 2019
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF RegistryRamon Corbalan, Jean-Pierre Bassand, Laura Illingworth, et al.
International Journal of Cardiology|February 21, 2012
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 yearsMark Y Chan, Jie-Lena Sun, L Kristin Newby, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillationKeith A A Fox, Saverio Virdone, Karen S Pieper, et al.
Pageof 23